Literature DB >> 10798963

The radioresponse of the central nervous system: a dynamic process.

P J Tofilon1, J R Fike.   

Abstract

Radiation continues to be a major treatment modality for tumors located within and close to the central nervous system (CNS). Consequently, alleviating or protecting against radiation-induced CNS injury would be of benefit in cancer treatment. However, the rational development of such interventional strategies will depend on a more complete understand-ing of the mechanisms responsible for the development of this form of normal tissue injury. Whereas the vasculature and the oligodendrocyte lineage have traditionally been considered the primary radiation targets in the CNS, in this review we suggest that other phenotypes as well as critical cellular interactions may also be involved in determining the radio-response of the CNS. Furthermore, based on the assumption that the CNS has a limited repertoire of responses to injury, the reaction of the CNS to other types of insults is used as a framework for modeling the pathogenesis of radiation-induced damage. Evidence is then provided suggesting that, in addition to acute cell death, radiation induces an intrinsic recovery/repair response in the form of specific cytokines and may

Entities:  

Mesh:

Year:  2000        PMID: 10798963     DOI: 10.1667/0033-7587(2000)153[0357:trotcn]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  162 in total

1.  Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.

Authors:  Sanath Kumar; Ali S Arbab; Rajan Jain; Jinkoo Kim; Ana C deCarvalho; Adarsh Shankar; Tom Mikkelsen; Stephen L Brown
Journal:  J Neurooncol       Date:  2012-03-10       Impact factor: 4.130

Review 2.  Renin-angiotensin system blockers and modulation of radiation-induced brain injury.

Authors:  M E Robbins; W Zhao; M A Garcia-Espinosa; D I Diz
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  Trauma-induced alterations in cognition and Arc expression are reduced by previous exposure to 56Fe irradiation.

Authors:  Susanna Rosi; Karim Belarbi; Ryan A Ferguson; Kelly Fishman; Andre Obenaus; Jacob Raber; John R Fike
Journal:  Hippocampus       Date:  2010-12-29       Impact factor: 3.899

4.  Delayed leukoencephalopathy of non-small cell lung cancer patients with brain metastases underwent whole brain radiation therapy.

Authors:  Xiaoling Zhong; Biao Huang; Jieying Feng; Wanqun Yang; Hongjun Liu
Journal:  J Neurooncol       Date:  2015-08-15       Impact factor: 4.130

Review 5.  Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction.

Authors:  DeeDee Smart
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

6.  Molecular pathways: radiation-induced cognitive impairment.

Authors:  Dana Greene-Schloesser; Elizabeth Moore; Mike E Robbins
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

7.  Behavioral consequences of radiation exposure to simulated space radiation in the C57BL/6 mouse: open field, rotorod, and acoustic startle.

Authors:  Michael J Pecaut; Paul Haerich; Cara N Zuccarelli; Anna L Smith; Eric D Zendejas; Gregory A Nelson
Journal:  Cogn Affect Behav Neurosci       Date:  2002-12       Impact factor: 3.282

Review 8.  Radiation-induced cognitive impairment--from bench to bedside.

Authors:  Dana Greene-Schloesser; Mike E Robbins
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 9.  Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy.

Authors:  Mark G Shaw; David L Ball
Journal:  Curr Treat Options Oncol       Date:  2013-12

10.  Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells.

Authors:  Munjal M Acharya; Lori-Ann Christie; Mary L Lan; Peter J Donovan; Carl W Cotman; John R Fike; Charles L Limoli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.